[go: up one dir, main page]

NO20023659L - Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser - Google Patents

Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser

Info

Publication number
NO20023659L
NO20023659L NO20023659A NO20023659A NO20023659L NO 20023659 L NO20023659 L NO 20023659L NO 20023659 A NO20023659 A NO 20023659A NO 20023659 A NO20023659 A NO 20023659A NO 20023659 L NO20023659 L NO 20023659L
Authority
NO
Norway
Prior art keywords
double
sebaceous gland
cholesterol ester
gland disorders
growth synthesis
Prior art date
Application number
NO20023659A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023659D0 (no
Inventor
Reynold Homan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20023659D0 publication Critical patent/NO20023659D0/no
Publication of NO20023659L publication Critical patent/NO20023659L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20023659A 2000-02-02 2002-08-01 Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser NO20023659L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17977800P 2000-02-02 2000-02-02
PCT/US2001/002190 WO2001056556A2 (en) 2000-02-02 2001-01-23 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders

Publications (2)

Publication Number Publication Date
NO20023659D0 NO20023659D0 (no) 2002-08-01
NO20023659L true NO20023659L (no) 2002-09-25

Family

ID=22657957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023659A NO20023659L (no) 2000-02-02 2002-08-01 Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser

Country Status (34)

Country Link
US (2) US6730703B2 (de)
EP (1) EP1263421B1 (de)
JP (1) JP2003531113A (de)
KR (1) KR20020073574A (de)
CN (1) CN1398182A (de)
AP (1) AP2002002612A0 (de)
AT (1) ATE295724T1 (de)
AU (1) AU781563B2 (de)
BG (1) BG107042A (de)
BR (1) BR0107954A (de)
CA (1) CA2398219A1 (de)
CR (1) CR6712A (de)
DE (1) DE60110897T2 (de)
DZ (1) DZ3288A1 (de)
EA (1) EA004255B1 (de)
EE (1) EE200200429A (de)
ES (1) ES2239145T3 (de)
GE (1) GEP20043286B (de)
HR (1) HRP20020717A2 (de)
HU (1) HUP0301010A3 (de)
IL (1) IL150865A0 (de)
IS (1) IS6478A (de)
MA (1) MA26872A1 (de)
MX (1) MXPA02007309A (de)
NO (1) NO20023659L (de)
NZ (1) NZ520330A (de)
OA (1) OA12173A (de)
PL (1) PL357041A1 (de)
PT (1) PT1263421E (de)
SK (1) SK10972002A3 (de)
UA (1) UA75345C2 (de)
WO (1) WO2001056556A2 (de)
YU (1) YU57502A (de)
ZA (1) ZA200206075B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1281399A3 (de) * 2001-08-01 2004-02-11 Warner-Lambert Company Hemmer mit doppelter Wirkung auf Wachsester- und Cholesterylestersynthese zur Hemmung der Sebumproduktion
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
CN1863521B (zh) 2003-10-09 2012-01-25 沃尼尔·朗伯有限责任公司 用于减少皮脂产生的包含丙二酰胺衍生物的药物组合物
BRPI0614028A2 (pt) 2005-02-24 2011-03-01 Warner Lambert Co inibidor cristalino de acat
FR2904002A1 (fr) * 2006-07-19 2008-01-25 Galderma Res & Dev S N C Snc Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2938342A1 (fr) * 2008-11-13 2010-05-14 Galderma Res & Dev Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
US20100226983A1 (en) 2009-01-28 2010-09-09 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
US20210260055A1 (en) * 2018-06-21 2021-08-26 Dermavant Sciences GmbH Topical formulations of dgat1 inhibitors and their methods of use

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US4751026A (en) 1986-03-24 1988-06-14 Warner-Lambert Company Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase
US4722927A (en) 1986-04-28 1988-02-02 Warner-Lambert Company Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
JPS6323848A (ja) 1986-07-11 1988-02-01 ワ−ナ−−ランバ−ト・コンパニ− Ω−(置換フエニルオキシ)−アルカン酸のアリ−ル−およびアラルキルアミド
US4716175A (en) 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
IE61716B1 (en) 1987-06-02 1994-11-30 Warner Lambert Co Antihyperlipidemic and antiatherosclerotic urea compounds
US5015644A (en) 1987-06-02 1991-05-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
DE3861988D1 (en) 1987-07-02 1991-04-18 Warner Lambert Co N-((2,6-disubstituierte)-phenyl)-harnstoff und -carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase.
US4948806A (en) 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5030653A (en) 1988-03-30 1991-07-09 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4999373A (en) 1988-03-30 1991-03-12 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5116848A (en) 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US5155127A (en) 1989-02-09 1992-10-13 Warner-Lambert Company N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4923896A (en) 1989-02-09 1990-05-08 Warner-Lambert Company N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4994465A (en) 1989-02-17 1991-02-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU632809B2 (en) 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
AU629376B2 (en) 1989-08-04 1992-10-01 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
MX22406A (es) 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
TW205037B (de) 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd
JPH05310678A (ja) 1990-01-22 1993-11-22 Mitsubishi Kasei Corp 1−フェニルアルキル−3−フェニル尿素誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
EP0623112B1 (de) 1992-01-23 1998-12-30 Pfizer Inc. 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxochinolin Derivate, als antihypercholesterolemische und antiatherosklerotische Mittel
EP0642498A1 (de) 1992-05-28 1995-03-15 Pfizer Inc. N-aryl und n-heteroaryl derivate als acat-hemmstoffe
US5565472A (en) 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US5596001A (en) 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
US5494172A (en) * 1994-05-12 1996-02-27 Miller Compressing Company Magnetic pulley assembly
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
JP2002518506A (ja) * 1998-06-25 2002-06-25 テュラリク インコーポレイテッド アリールスルホンアニリドホスフェート
PE20020453A1 (es) * 2000-09-27 2002-06-06 Merck & Co Inc Derivados del acido benzopirancarboxilico para el tratamiento de la diabetes y los trastornos de lipidos

Also Published As

Publication number Publication date
ES2239145T3 (es) 2005-09-16
CN1398182A (zh) 2003-02-19
US20040161393A1 (en) 2004-08-19
NZ520330A (en) 2004-02-27
US20030060507A1 (en) 2003-03-27
EA200200764A1 (ru) 2002-12-26
EP1263421B1 (de) 2005-05-18
AU2971801A (en) 2001-08-14
OA12173A (en) 2006-05-08
UA75345C2 (en) 2006-04-17
SK10972002A3 (sk) 2003-07-01
MXPA02007309A (es) 2002-11-29
DE60110897D1 (de) 2005-06-23
WO2001056556A2 (en) 2001-08-09
US6730703B2 (en) 2004-05-04
CR6712A (es) 2004-01-14
HRP20020717A2 (en) 2003-12-31
NO20023659D0 (no) 2002-08-01
JP2003531113A (ja) 2003-10-21
HUP0301010A3 (en) 2005-03-29
KR20020073574A (ko) 2002-09-27
AU781563B2 (en) 2005-06-02
CA2398219A1 (en) 2001-08-09
GEP20043286B (en) 2004-07-26
DE60110897T2 (de) 2006-03-23
DZ3288A1 (en) 2001-08-09
EP1263421A2 (de) 2002-12-11
EA004255B1 (ru) 2004-02-26
MA26872A1 (fr) 2004-12-20
IS6478A (is) 2002-07-19
AP2002002612A0 (en) 2002-09-30
BG107042A (bg) 2003-04-30
EE200200429A (et) 2003-12-15
YU57502A (sh) 2006-01-16
PT1263421E (pt) 2005-08-31
ZA200206075B (en) 2003-10-30
IL150865A0 (en) 2003-02-12
WO2001056556A3 (en) 2002-03-07
ATE295724T1 (de) 2005-06-15
PL357041A1 (en) 2004-07-12
BR0107954A (pt) 2002-10-22
HUP0301010A2 (hu) 2003-08-28

Similar Documents

Publication Publication Date Title
NO20025377D0 (no) FremgangsmÕte for fremstilling av dihydroksyestere og derivater derav
IS1940B (is) Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
NO20025588D0 (no) Inhibitorer for 11-beta-hydroxy steroid dehydrogenase type 1
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
ITMI20011269A0 (it) Pannello isolante e procedimento per la sua realizzazione
NO20032986L (no) Metoder og blandinger for påvisning av forbindelser som modulerer inflammatoriske responser
NO20023659L (no) Dobbelt inhibitorer av kolesterolester og voksestersyntese for talgkjertelforstyrrelser
NO20013818L (no) Mikrobiell fremgangsmåte for fremstilling av pravastatin
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
EP1456377A4 (de) Syn3-zusammensetzungen und verfahren
AU7445100A (en) Sebum production inhibitors
GB2360646B (en) Method of displaying full-charge-state
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20034994D0 (no) Fremgangsmåte for å uttrykke langkjedet prenyldifosfatsyntese
DE60008319D1 (de) IL-12 Produktionsinhibitor
DK1263421T3 (da) Den dobbelte inhibitor af cholesterylester- og voksestersyntese avasimibe til behandling af talgkirtel-lidelser
AU2002218555A1 (en) Operation system of exhibition site for internet
NO20015760L (no) Fibrinforseglinger som tilveiebringer mindre betennelsesrespons og fremgangsmater for bruk av samme
NO20031847L (no) Sammensetninger og fremgangsmåter for oppdagelse og seleksjon av biologiskinformasjon
NO20035297D0 (no) Fremgangsmåte for fremvisning av data
IT1317859B1 (it) Metodo per la selezione e la crescita di oociti competenti per losviluppo embrionale.
AU2002257602A1 (en) Simple method for the synthesis of boswellic acids and derivatives thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application